Literature DB >> 35137303

A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.

Ryota Sato1,2, Kohsuke Kudo3, Niki Udo4, Masaaki Matsushima5, Ichiro Yabe5, Akinori Yamaguchi3, Khin Khin Tha6, Makoto Sasaki7, Masafumi Harada8, Noriyuki Matsukawa9, Tomoki Amemiya10, Yasuo Kawata11, Yoshitaka Bito3,11, Hisaaki Ochi10,3, Toru Shirai10,3.   

Abstract

OBJECTIVES: Voxel-based morphometry (VBM) is widely used to quantify the progression of Alzheimer's disease (AD), but improvement is still needed for accurate early diagnosis. We evaluated the feasibility of a novel diagnosis index for early diagnosis of AD based on quantitative susceptibility mapping (QSM) and VBM.
METHODS: Thirty-seven patients with AD, 24 patients with mild cognitive impairment (MCI) due to AD, and 36 cognitively normal (NC) subjects from four centers were included. A hybrid sequence was performed by using 3-T MRI with a 3D multi-echo GRE sequence to obtain both a T1-weighted image for VBM and phase images for QSM. The index was calculated from specific voxels in QSM and VBM images by using a linear support vector machine. The method of voxel extraction was optimized to maximize diagnostic accuracy, and the optimized index was compared with the conventional VBM-based index using receiver operating characteristic analysis.
RESULTS: The index was optimal when voxels were extracted as increased susceptibility (AD > NC) in the parietal lobe and decreased gray matter volume (AD < NC) in the limbic system. The optimized proposed index showed excellent performance for discrimination between AD and NC (AUC = 0.94, p = 1.1 × 10-10) and good performance for MCI and NC (AUC = 0.87, p = 1.8 × 10-6), but poor performance for AD and MCI (AUC = 0.68, p = 0.018). Compared with the conventional index, AUCs were improved for all cases, especially for MCI and NC (p < 0.05).
CONCLUSIONS: In this preliminary study, the proposed index based on QSM and VBM improved the diagnostic performance between MCI and NC groups compared with the VBM-based index. KEY POINTS: • We developed a novel diagnostic index for Alzheimer's disease based on quantitative susceptibility mapping (QSM) and voxel-based morphometry (VBM). • QSM and VBM images can be acquired simultaneously in a single sequence with little increasing scan time. • In this preliminary study, the proposed diagnostic index improved the discriminative performance between mild cognitive impairment and normal control groups compared with the conventional VBM-based index.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Alzheimer disease; Diagnosis, computer-assisted; Early diagnosis; Iron; Magnetic resonance imaging

Mesh:

Year:  2022        PMID: 35137303     DOI: 10.1007/s00330-022-08547-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker.

Authors:  Sanneke van Rooden; Maarten J Versluis; Michael K Liem; Julien Milles; Andrea B Maier; Ania M Oleksik; Andrew G Webb; Mark A van Buchem; Jeroen van der Grond
Journal:  Alzheimers Dement       Date:  2013-05-25       Impact factor: 21.566

2.  Simultaneous voxel-based magnetic susceptibility and morphometry analysis using magnetization-prepared spoiled turbo multiple gradient echo.

Authors:  Hirohito Kan; Yuto Uchida; Nobuyuki Arai; Yoshino Ueki; Toshitaka Aoki; Harumasa Kasai; Hiroshi Kunitomo; Yasujiro Hirose; Noriyuki Matsukawa; Yuta Shibamoto
Journal:  NMR Biomed       Date:  2020-02-11       Impact factor: 4.044

3.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

Authors:  J M G van Bergen; X Li; J Hua; S J Schreiner; S C Steininger; F C Quevenco; M Wyss; A F Gietl; V Treyer; S E Leh; F Buck; R M Nitsch; K P Pruessmann; P C M van Zijl; C Hock; P G Unschuld
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

4.  In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease.

Authors:  Julio Acosta-Cabronero; Guy B Williams; Arturo Cardenas-Blanco; Robert J Arnold; Victoria Lupson; Peter J Nestor
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.